Even as SARS-CoV-2 lab leak hypothesis is based on conjectures, it needs to be investigated
Much like other viruses, SARS-CoV-2 too could have a natural origin after it jumped from animals to humans or could
Read More
Author: Prasad Ravindranath
Amidst shortage, allotting 25% of COVID-19 vaccines produced to private hospitals will aggravate vaccine inequity
In an email, Dr. Gagandeep Kang, Professor of Microbiology at CMC Vellore and Dr. Chandrakant Lahariya, physician-epidemiologist and a vaccines
Read More
Two vaccine doses offer 77% protection against hospitalisation, CMC Vellore study finds
The study has been published in the journal Mayo Clinic Proceedings. “Our study shows that COVID-19 vaccines have a great
Read More
Covaxin offers protection against beta and delta variants, says study
The study evaluated the neutralisation potential in people vaccinated with Covaxin and found that there was a 3- and 2.7-fold
Read More
Study finds Covishield produces more antibodies than Covaxin, but scientists point out serious flaws with the preprint
The seropositivity rates and the median antibody titre against spike protein was “significantly higher” in those vaccinated with Covishield compared
Read More
‘We need to stay prepared for multiple waves and variants’
With the alpha (B.1.1.7) and delta (B.1.617.2) variants widely present across the country, and the possibility of new variants with
Read More
I would be reluctant to change Covishield dose interval at a time when we still have intense transmission: Gagandeep Kang
After approving Covishield vaccination with a four-six-week interval between two doses despite evidence showing higher protection when the gap was
Read More
COVID-19: Government passes off factually incorrect vaccination information as ‘fact’
According to the PIB release, the myth was that the Centre wasn’t taking any step to vaccinate children. Clarifying this,
Read More
Rising cases of mucormycosis throws up another challenge in the second wave
A concerned Health Ministry has now asked all States to classify mucormycosis, a fungal infection, as a notifiable disease under
Read More
Serum’s supply to COVAX hit by India’s poor vaccination planning
On August 7, a week before Mr. Modi’s announcement, the Pune-based Serum Institute signed an agreement with GAVI and Gates
Read More
Vaccine shortage will affect all eligible groups
The two private vaccine manufacturers — Serum Institute and Bharat Biotech — are required to supply 50% of vaccine produced
Read More
Covaxin offers protection against double mutant (B.1.617) variant
A preprint of the study carried out by ICMR and Bharat Biotech researchers has been posted in biorXiv. Preprints are
Read More
India sets a dangerous precedent with COVID-19 vaccination programme
A large percentage of those aged 18-44 years does not have the resources to pay for vaccines and hence will
Read More